Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: Photo/Multimedia

Enterprise Resource Planning Software Market | Insights on the Crisis and the Roadmap to Recovery from COVID-19 Pandemic | Technavio


The global enterprise resource planning software market to register an incremental growth of USD 19.52 billion, witnessing a CAGR of almost 9% during 2020-2024, according to the latest market research analysis by Technavio. The report offers a detailed analysis of the impact of COVID-19 pandemic on the enterprise resource planning software market in optimistic, probable, and pessimistic forecast scenarios.

Get detailed insights on COVID-19 pandemic Crisis and Recovery analysis of Enterprise Resource Planning Software market. Download free report sample

Amid the COVID-19 Crisis, the Revaluated and Updated Enterprise Resource Planning Software Market Report Says:

Click here to learn about the report's detailed analysis and insights on how you can leverage them to grow your business.

Enterprise Resource Planning Software Market Segmentation and Competitive Analysis

Enterprise resource planning software market is segmented by type (cloud-based and on-premise) and geography (APAC, Europe, MEA, North America, and South America). Increasing demand for cloud-based applications has been an instrumental factor in influencing the growth of enterprise resource planning software market. Other market drivers include increasing demand for ERP software from SMEs and increased operational efficiency associated with ERP software.

The market is fragmented. The report analyzes the market's competitive landscape and offers information on several market vendors, including Acumatica Inc., Epicor Software Corp., IFS AB, Infor Inc., Microsoft Corp., Oracle Corp., Sage Group Plc, Salesforce.com Inc., SAP SE, and ServiceNow Inc. Moreover, Technavio offers custom research analysis on the crucial pointers to highlight the impact of COVID-19 on the market across the supply chain.

Gain instant access to 17,000+ market research reports by using

Technavio's SUBSCRIPTION platform

Reasons to Buy the Report:

Have Any Special Requirements OR Want to Customize This Report According to Your Needs? Speak to Our Analyst and Get $1000 Worth of FREE Customization at the Time of Purchase

Methodology

Information Sources:

Primary sources

Secondary sources

Data Analysis:

Data Synthesis

Data Validation

Report Writing:

Qualitative

Quantitative

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: